Optimal Dose and Type of β-blockers in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

  • Jiesuck Park
  • , Jung Kyu Han
  • , Jeehoon Kang
  • , In Ho Chae
  • , Sung Yun Lee
  • , Young Jin Choi
  • , Jay Young Rhew
  • , Seung Woon Rha
  • , Eun Seok Shin
  • , Seong Ill Woo
  • , Han Cheol Lee
  • , Kook Jin Chun
  • , Doo Il Kim
  • , Jin Ok Jeong
  • , Jang Whan Bae
  • , Han Mo Yang
  • , Kyung Woo Park
  • , Hyun Jae Kang
  • , Bon Kwon Koo
  • , Hyo Soo Kim*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Optimal Dose and Type of β-blockers in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science